Drugs / G-CSF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT03531918 Background | Sep 2018 → Jul 2021 | acute myeloid leukemia | Fred Hutchinson Cancer Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | “Participants also receive G-CSF subcutaneously (SC) on days 0-5” NCT03531918 ↗ |
| Route | Subcutaneous | “Given SC” NCT03531918 ↗ |